Ductal pancreatic cancer interception by FGFR2 abrogation
Claudia Tonelli, Astrid Deschênes, Victoria A. Gaeth, Amanda Jensen, Nandan Vithlani, Melissa A. Yao, Zhen Zhao, Youngkyu Park, David Arthur Tuveson
This study identifies FGFR2 as a key driver in early pancreatic tumorigenesis, showing that its inhibition can delay tumor formation and extend survival in mouse models.
Cancer Research · Apr 2, 2025Peer-reviewedCancer Biology